AI assistant
CONMED Corp — Director's Dealing 2021
May 4, 2021
31971_dirs_2021-05-04_941c929a-f4e3-4ee2-a0c0-3ef082129a98.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-04-30
Reporting Person: Jonas Daniel S (EVP Legal Affairs,Gen. Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-30 | Common Stock | M | 700 | $41.93 | Acquired | 14506 | Direct |
| 2021-04-30 | Common Stock | S | 600 | $142.581 | Disposed | 13906 | Direct |
| 2021-04-30 | Common Stock | S | 100 | $143.30 | Disposed | 13806 | Direct |
| 2021-04-30 | Common Stock | M | 10000 | $41.93 | Acquired | 23806 | Direct |
| 2021-04-30 | Common Stock | S | 10000 | $141.075 | Disposed | 13806 | Direct |
| 2021-04-30 | Common Stock | M | 5000 | $59.96 | Acquired | 18806 | Direct |
| 2021-04-30 | Common Stock | S | 5000 | $142.00 | Disposed | 13806 | Direct |
| 2021-05-03 | Common Stock | M | 4176 | $41.93 | Acquired | 17982 | Direct |
| 2021-05-03 | Common Stock | S | 4176 | $145.5906 | Disposed | 13806 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-30 | Options To Purchase Common Stock | $41.93 | M | 700 | Disposed | 2027-03-01 | Common Stock (700) | Direct |
| 2021-04-30 | Options To Purchase Common Stock | $41.93 | M | 10000 | Disposed | 2027-03-01 | Common Stock (10000) | Direct |
| 2021-04-30 | Options To Purchase Common Stock | $59.96 | M | 5000 | Disposed | 2028-03-01 | Common Stock (5000) | Direct |
| 2021-05-03 | Options To Purchase Common Stock | $41.93 | M | 4176 | Disposed | 2027-03-01 | Common Stock (4176) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.10 to $142.725. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.00 to $141.17. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.52 to $145.61. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.